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Structure of TPR Domain±Peptide Complexes:
Critical Elements in the Assembly of the
Hsp70±Hsp90 Multichaperone Machine
an adaptor protein that provides specific binding sites
for these two major chaperones (Chang et al., 1997;
Frydman and HoÈ hfeld, 1997; Chen and Smith, 1998;
Johnson et al., 1998).
Hop is composed almost exclusively of TPR (tet-
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domains consist of three or more TPR motifs, which areBiology
highly degenerate 34 amino acid repeats (Lamb et al.,D22603 Hamburg
1995). Hop was predicted to contain nine TPR motifs inGermany
its sequence, forming two TPR domains. Based on the
analysis of deletion mutants, the N-terminal TPR domain
of Hop, TPR1 (three TPR motifs), is responsible for theSummary
interaction with the C terminus of Hsp70, and a C-ter-
minal TPR2 domain (six TPR motifs) primarily mediatesThe adaptor protein Hop mediates the association of
the interaction of Hop with Hsp90 (Chen et al., 1996;the molecular chaperones Hsp70 and Hsp90. The
Lassle et al., 1997; Demand et al., 1998). Hop inhibitsTPR1 domain of Hop specifically recognizes the C-ter-
the Hsp90 ATPase (Prodromou et al., 1999) and blocksminal heptapeptide of Hsp70 while the TPR2A domain
access of ATP or the inhibitor geldanamycin to its bind-binds the C-terminal pentapeptide of Hsp90. Both se-
ing pocket in the N-terminal domain of Hsp90 (Prodro-quences end with the motif EEVD. The crystal struc-
mou et al., 1997, 1999; Stebbins et al., 1997). As withtures of the TPR±peptide complexes show the pep-
Hsp70, the binding site for Hop on Hsp90 has beentides in an extended conformation, spanning a groove
mapped to the C-terminal domain of the chaperonein the TPR domains. Peptide binding is mediated by
(Young et al., 1998; Carrello et al., 1999). The integrityelectrostatic interactions with the EEVD motif, with
of the conserved C-terminal EEVD motif in Hsp90 isthe C-terminal aspartate acting as a two-carboxylate
essential for the interaction (Chen et al., 1998). Theanchor, and by hydrophobic interactions with residues
C-terminal domain of Hsp90 also binds a number ofupstream of EEVD. The hydrophobic contacts with the
other TPR containing cochaperones, including the largepeptide are critical for specificity. These results ex-
immunophilins Cyp-40, FKBP51, and FKBP52, and theplain how TPR domains participate in the ordered as-
serine±threonine phosphatase PP5 (Pratt and Toft, 1997;sembly of Hsp70±Hsp90 multichaperone complexes.
Dolinski et al., 1998; Marsh et al., 1998; Buchner, 1999).
Competition experiments suggest the existence of only
one TPR acceptor site within this region (Owens-Grillo
Introduction
et al., 1996; Young et al., 1998). Like the TPR1 domain
of Hop, the recently identified TPR protein CHIP also
Some cellular signaling proteins require the coordinated binds to the C terminus of Hsp70 (Ballinger et al., 1999).
activities of the Hsp70 and Hsp90 molecular chaperones From multiple sequence alignments, it is clear that
for their folding and conformational regulation. These there are no strictly conserved residues within the 34
substrates include the nuclear receptors of steroid hor- amino acid TPR module. There is, however, a strong
mones and several proto-oncogenic serine/threonine preference for small hydrophobic amino acids at certain
and tyrosine kinases, such as Raf and Src (Pratt, 1997; positions (Lamb et al., 1995). The crystal structure of
Buchner, 1999; Caplan, 1999). the peptide-free TPR domain of protein phosphatase 5
Many polypeptide chains interact cotranslationally (PP5), which binds to Hsp90, showed that each TPR
with chaperones of the Hsp70 family, which act in pre- forms a helix-turn-helix motif, with adjacent TPR motifs
venting misfolding and aggregation of nascent chains. being packed into a regular series of antiparallel a heli-
Newly synthesized polypeptides are either released for ces (Das et al., 1998). It has been suggested that TPR
folding to their native state without the help of additional domains might recognize elements of higher order
chaperones or are passed on to more specialized chap- structure, such as a helices or tertiary structure (Das et
erone systems (Hartl, 1996; Johnson and Craig, 1997). al., 1998). However, in the absence of a specific binding
Of these downstream systems in the eukaryotic cytosol, partner, the structural basis for TPR-mediated protein
the chaperonin TriC/CCT and the Hsp90 multichaperone recognition remained unclear. Here, we report the crys-
machinery have been best characterized. Hsp90 re- tal structures of the N-terminal TPR domain of Hop
ceives its substrates from Hsp70 in a reaction that is (TPR1) in the presence of a bound peptide consisting
critically dependent on the function of Hop (Hsp70 and of the C-terminal 12 amino acids of Hsc70 and of a
Hsp90 organizing protein, also known as p60 or Sti1p), C-terminal domain (TPR2A) in complex with a peptide
representing the five C-terminal residues of Hsp90. The
structures provide insight into how TPR domain cochap-³ To whom correspondence should be addressed (e-mail: moarefi@
erones specifically recognize Hsp70 and Hsp90 proteinsbiochem.mpg.de).
§ These authors contributed equally to this work. and explain the conservation of the EEVD motif in all
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Figure 1. Interaction of the TPR1 Domain of Hop with Hsc70/Hsp70
(A) Organization of the Hop coding region. The boundaries of the TPR1, TPR2A, and TPR2B domains are indicated.
(B) Calorimetric isothermal titration measurement of the interaction of the Hop TPR1 domain with the C-terminal 25 kDa domain of Hsp70
(C70). Top part: incremental heat effect upon titration of C70 (180 mM) with TPR1 (3 mM) at 258C. Lower part: integrated heat effects normalized
to the amount of injected TPR1 and fitted curve based on a 1:1 binding model. Constants determined were KD 5 15 mM, stoichiometry N 5 0.87.
(C) Thermodynamic binding constants (KD) for the interactions of TPR1 with C70 and peptides comprising the last 12 residues of Hsp70 and
Hsc70 (upper part), and for the binding of TPR2A to C90 and a Hsp90 pentapeptide (lower part). Titrations were performed at 258C by injecting
proteins or peptides into a solution containing TPR domains. Stoichiometry factors (N) typically ranged between 0.9 and 1.1. The ITC
measurements were highly reproducible, with standard deviations for triplicate measurements ranging between 5% and 10%.
Hsp70 and Hsp90 family members known to interact (amino acids 629±732) bound to TPR2A with an affinity
of 6 mM and a stoichiometry factor close to one (Figurewith TPR proteins.
1C). A peptide comprising only the last five residues of
Hsp90 still bound to TPR2A with an affinity of 11 mM
Results and Discussion (Figure 1C).
Thus, the binding of TPR1 to C70 can be fully de-
Peptide Binding by Hop TPR Domains scribed by the interaction of TPR1 with a 12-mer C-ter-
Hop has previously been shown by sequence analysis minal peptide of Hsp70, while the interaction of TPR2A
to contain two clusters of TPR elements (Chen et al., with C90 is essentially mediated by the five C-terminal
1996; Lassle et al., 1997). Utilizing limited proteolysis to residues of Hsp90. The affinities measured are compara-
define the domains of human Hop, three stable frag- ble to those determined for the interaction of SH3 do-
ments could be identified: TPR1, TPR2A, and TPR2B mains with their peptide ligands (Kuriyan and Cowburn,
(Figure 1A; C. S. and I. M., unpublished data). We ex- 1997).
pressed and purified fragments corresponding to the
N-terminal TPR1 domain (amino acids 1±118) and the Structures of the TPR Domain±Peptide Complexes
middle domain TPR2A (amino acids 223±352). Isother- We crystallized the TPR1 and TPR2A domains of Hop
mal calorimetric (ITC) measurements (Wiseman et al., in complex with their respective peptide partners and
1989) demonstrated that a 25 kDa fragment of human solved the high resolution crystal structures of the two
Hsp70 (C70), retaining the substrate binding domain and complexes (see Experimental Procedures). Both TPR
the authentic C terminus of Hsp70, bound to TPR1 with domains form a meander of seven a helices (Figures 2A
an affinity of 15 mM and a stoichiometry factor (N) of and 2E) which are arranged in a head to tail manner
close to 1 (Figures 1B and 1C). The same affinities were similar to that of the peptide-free TPR domain of PP5
obtained with 12-mer peptides of the nearly identical C (Das et al., 1998). Compared to TPR1 and the TPR do-
termini of Hsp70 and Hsc70 as ligands (Figure 1C). A main of PP5, TPR2A contains an insertion between re-
12 kDa fragment of Hsp90 (C90) that includes the dimer- peat two and three which leads to elongation of helices
B2 and A3 by one turn each (Figures 2E and 3). In bothization domain and the authentic C terminus of Hsp90
Crystal Structures of the TPR Domain±Peptide Complexes
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Figure 2. Ribbon and Surface Representation of the TPR±Peptide Complexes
The backbone of the TPR domains is shown as a ribbon representation in magenta (TPR1) or cyan (TPR2A), and the bound peptides are
depicted as stick models in pink. The N and C termini of the TPR domains and the bound peptides are indicated by the labels N and C,
respectively. Helices A and B of the three consecutive TPR motifs, as well as the flanking helix C are indicated.
(A and E) Top view of the cradle-shaped TPR1 and TPR2A domains.
(B and F) The same complexes as in (A) and (E) but rotated by 90 degrees with the two-carboxylate anchor of the peptide pointing toward
the viewer.
(C and G) A 2Fo-Fo electron density map was calculated for the peptide region using the final model from which the peptide was omitted
following simulated annealing to remove model bias. Same view as in (A) and (E). All figures were prepared using Bobscript (Esnouf, 1999)
and rendered in Raster3d (Merritt and Bacon, 1997).
(D and H) Representation of the electrostatic potential of TPR1 and TPR2A modeled onto the accessible molecular surface as calculated and
visualized in GRASP (Nicholls et al., 1993). Red, negatively charged; blue, positively charged and gray, neutral. The bound peptides are shown
in a stick representation.
structures, helix C, which is positioned C-terminal to the with sidechains of the A helices of the TPR domains
that line the inner surface of the cradle (Figures 2B andthree TPR consensus blocks, appears to be an integral
part of the TPR domain (Figure 2). 2F). The simulated annealing 2Fo-Fo electron density
map of the TPR1-bound peptide, calculated without in-The TPR meanders form cradle-shaped grooves that
accommodate the peptides in an extended conforma- cluding the peptide, shows that the last seven peptide
residues are very well defined in the complex with TPR1tion (Figure 2). The bound peptides only make contact
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Figure 3. Structure-Based Alignment of TPR Domains of Proteins that Bind to either Hsp70 or Hsp90
TPR residues of the highly conserved two-carboxylate clamp and additional residues involved in electrostatic interactions with the EEVD
motif are highlighted in cyan, and residues mainly involved in hydrophobic and van der Waals contacts with the peptides are shown in red.
Residues marked in bold black are part of the TPR consensus and are conserved because of packing interactions between different a helices
of neighboring TPR motifs. All sequences are taken from GenBank and are of human origin, except for CNS1 and TOM70 which are from S.
cerevisiae and N. crassa, respectively. Hsp70-binding TPR domains: TPR1 and CHIP. Hsp90-binding TPR domains: TPR2A, PP5, FKBP51,
FKBP52, CYP40, TOM34, TOM70, and CNS1. The ligand for TPR2B has not yet been identified. The other sequences represent putative Hsp70
or Hsp90-binding TPR domains: TTC1 and TTC2 are interaction partners of neurofibromin (Murthy et al., 1996). TTC3 lies within a genomic
region implicated in the pathology of Down's syndrome (Tsukahara et al., 1996), TTC4 is located in a region frequently deleted in sporadic
breast cancer (Su et al., 1999), IRSP is an infertility-related sperm protein (Zhang et al., 1992), and SGT (small glutamine-rich TPR protein) is
thought to interact with the nonstructural protein NS1 from parvovirus H-1 (Kordes et al., 1998). The human protein KIAA0719 is of unknown
function (Nagase et al., 1998).
(Figure 2C). A similar map calculated for the peptide chains of the Hsp90 peptide are engaged in interactions
with TPR2A (Figure 4B). All electrostatic contacts be-bound to TPR2A shows that all five residues of the
bound peptide are well-ordered (Figure 2G). The ex- tween the TPR domains and the peptides occur in the
regions of the EEVD motif, whereas the regions of thetended conformation of the peptides allows for the dis-
play of a maximized surface toward the TPR domains bound peptides that lie N-terminal to the EEVD motif
are engaged exclusively in hydrophobic and van derand thus facilitates the specific recognition of short
amino acid stretches with sufficient affinity. Waals interactions (Figures 4A and 4B).
In the following description of the TPR±peptide com-
plexes, the C-terminal Asp residue of the peptides will
A Highly Conserved Two-Carboxylate Clamp Anchorsbe referred to as Asp 0. The preceding residues will be
the EEVD Motif to TPR1 and TPR2Anumbered in descending order as Val 21, Glu 22, Glu
Three kinds of hydrogen-bonding interactions are in-23, Ile 24, Thr 25, Pro 26, and Gly 27 for the Hsp70
volved in mediating peptide binding to TPR1 and TPR2A:peptide (Figure 4A) and as Met 24 for the Hsp90 peptide
Sequence independent interactions with the peptide(Figure 4B), respectively. Only the last eight residues in
backbone, sequence specific interactions with peptidethe 12 residue Hsp70 peptide are ordered in the TPR1
sidechains, and contacts with the C-terminal mainchaincomplex and thus visible in the final electron density
carboxylate of the last peptide residue Asp 0 (Figuresmap. The peptide sidechains of Pro 26, Ile 24, Val 21,
4A and 4B). As will be discussed below, these latterand Asp 0 are involved in contacts with TPR1. The re-
contacts and electrostatic interactions with the main-maining sidechains in the ordered part of the peptide, in
chain carboxylate of Asp 0 form a two-carboxylateparticular the two nearly absolutely conserved glutamic
clamp that is highly conserved between the two com-acid sidechains at position 22 and 23, are solvent ex-
plexes.posed (Figures 2C and 4A). In the TPR2A complex, all
Most of the direct hydrogen bonding interactions fromfive peptide residues are clearly visible in the final elec-
tron density map. With the exception of Glu 22, all side- the TPR domains to the Hsp peptides target the peptide
Crystal Structures of the TPR Domain±Peptide Complexes
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Figure 4. Schematic Representation of the TPR±Peptide Interactions
(A) TPR1±peptide complex.
(B) TPR2A±peptide complex.
Generated with the program Ligplot (Wallace et al., 1995).
backbone and thus do not exploit sequence-specific hydroxyl of Ser 42. The electrostatic interactions of
TPR2A with the Hsp90 peptide are very similar to thosefeatures. In the TPR1 complex (Figure 4A), direct back-
bone contacts involve the sidechain carbonyl of Asn 43 in the TPR1 complex, with some differences. TPR2A is
donating two hydrogen bonds to the sidechain of Aspin TPR1, which contacts the backbone amide of Asp 0
of the Hsp70 peptide and the sidechain amine of Lys 0 via Lys 301 and the sidechain amide of Gln 298. As
in the TPR1 complex, a tetrahedrally coordinated water73 that binds to the mainchain carbonyl of peptide resi-
due Glu 22. Arg 77 of TPR1 plays a key role in binding the molecule is in contact with the Asp 0 sidechain posi-
tioned by the sidechain carbonyl of Asn 264, the guanidi-backbone of the peptide. Its guanidinium group makes
three direct hydrogen bonds with peptide carbonyls; nium group of Arg 305, and the sidechain amide of Asn
233 (Figure 4A). In contrast to the TPR1 complex, in theone at the 22 and two at the 23 position. An additional
hydrogen bond to the carbonyl of Glu 23 is mediated TPR2A complex, the sidechain of Glu 23 is engaged in
a tight hydrogen bonding network with the TPR domain.by a tightly bound water molecule positioned by Lys 50
in TPR1 (Figure 4A). In the TPR2A complex, the sidechain It is directly contacted by the guanidinium group of Arg
305 and the sidechain amide of Asn 308, and additionallycarbonyl of Asn 264 contacts the backbone amide of
Asp 0 of the Hsp90 peptide, the guanidinium group of is integrated in a network of indirect interactions involv-
ing ordered water molecules (Figure 4B).Arg 305 hydrogen bonds with the the mainchain car-
bonyl of Glu 22, the hydroxyl group of Tyr 236 with that In both TPR complexes, the mainchain carboxylate
of Asp 0 is held in place by three additional strongof Glu 23, and the sidechain of Glu 271 contacts the
amide of Glu 23. Additionally, the hydroxyl group of Tyr hydrogen bonds with the sidechain amines of Lys 8 (Lys
229), Asn 12 (Asn 233), and Asn 43 (Asn 264) of the TPR1236 contacts the mainchain carbonyl of Glu 23.
The only peptide sidechain in the TPR1 complex that and TPR2A domains, respectively.
In addition to the described electrostatic interactionsis recognized via an electrostatic interaction is the side-
chain carboxylate of Asp 0 that interacts with Lys 73 between the TPR domains and the EEVD motif of the
bound peptides, peptide residue Val 21 engages in hy-(Figure 4A). An additional sidechain contact is mediated
by an ordered water molecule that is tetrahedrally coor- drophobic and van der Waals contacts which are also
mostly conserved between the two complexes (Figuresdinated by the sidechain carbonyls of Asp 0 and Asn
43, the guanidinium group of Arg 77, and the sidechain 4A and 4B).
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human proteins that are implicated in disease (listed in
Figure 3). It seems likely that at least some of these TPR
proteins are cochaperones of Hsp70 or Hsp90.
Hydrophobic Interactions with Residues Upstream
of EEVD Provide Hsp Specificity
The electrostatic interactions of TPR1 and TPR2A with
the EEVD motif described above cannot discriminate
between the C termini of Hsp70 and Hsp90, raising the
important question of how specificity in TPR±Hsp bind-
ing is achieved. It is apparent from the structures of
the TPR±peptide complexes that additional contacts are
made with peptide residues N-terminal to the EEVD mo-
tif (Figures 4 and 5). These contacts are critical for pep-
tide binding with a physiologically relevant high affinity
(Figure 6A). Whereas the C-terminal heptamer peptide
of Hsc70 bound to TPR1 with the same affinity as the
complete C-terminal domain of Hsp70/Hsc70, trunca-
tion of the residues N-terminal to the EEVD motif re-
sulted in a sharp drop in the affinity from 15±20 mM to
about 300 mM. Furthermore, the peptide IEEVD that is
equivalent in length to the Hsp90 peptide bound with
an affinity of only 140 mM, significantly weaker than theFigure 5. Superposition of the Two TPR±Peptide Complexes
heptamer peptide (Figure 6A).Superposition of the two-carboxylate clamps of the TPR1± and
The buried surface area for the structured octamerTPR2A±peptide complexes results in the alignment of the sidechains
peptide in the TPR1 complex is 1330 AÊ 2, but is onlythat mediate peptide contacts as well as parts of the bound pep-
tides. The colors for residues of TPR1, TPR2A, and the peptides 650 AÊ 2 for the four residues of the EEVD motif. The
are as in Figure 2. The residues of the two-carboxylate clamp and critical contacts responsible for the z20-fold increase
the peptide N and C termini are indicated. in affinity involve exclusively hydrophobic and van der
Waals interactions of TPR1 with the sidechains of Ile
24 and Pro 26 of the Hsc70 peptide (Figure 4A). EachAs described above, the five amino acids of TPR1
of the hydrophobic contacts of the peptide with TPR1that are involved in electrostatic interactions with the
is mainly restricted to one particular A helix. Pro 26 isEEVD motif (Lys 8, Asn 12, Asn 43, Lys 73, and Arg 77)
positioned in a hydrophobic cavity formed by Glu 83form a two-carboxylate clamp that tightly interacts with
and Phe 84 of helix A3, and Ile 24 binds in a cavitythe ultimate Asp residue of the bound peptide. These
formed by residues Ala 46, Ala 49, and Lys 50 of helixresidues align well with the equivalent residues of
A2. Val 21, the hydrophobic residue within the EEVD
TPR2A (Lys 229, Asn 233, Asn 264, Lys 301, and Arg
motif, makes hydrophobic contacts with Asn 12 and Leu
305) when their Ca atoms are superimposed (Figure 5).
15 in helix A1 and with Asn 43 in helix A2.
The rmsd for the five positions of the two-carboxylate In the TPR2A complex, the bound peptide is signifi-
clamp is 0.75 AÊ , compared to 1.75 AÊ for the entirety of cantly shorter than in the TPR1 complex. The overall
the domains. Except for Lys 73 (Lys 301), all sidechains buried surface area in the TPR2A/MEEVD complex is
are virtually at the same position in the two structures. 930 and 750 AÊ 2 for the residues EEVD. Nevertheless, the
The alignment also leads to the superposition of the two measured affinities of the Hsp90 MEEVD pentapeptide
bound peptides. It is apparent that positions Asp 0 and for TPR2A are in the same range as the affinities of the
Val 21 superimpose remarkably well, whereas the rest Hsp70 GPTIEEVD peptide for TPR1, and longer peptides
of the two peptides diverges increasingly from C to N do not bind with higher affinity (Figure 6B). The two
terminus, utilizing different regions for interaction with additional hydrogen bonds donated by TPR2A to Glu
their respective TPR domain (see below). 23 of the peptide seem to compensate the smaller hy-
Notably, the sidechain residues of the TPR1 and drophobic interaction surface (Figure 4B). As a conse-
TPR2A domains that form the two-carboxylate clamp quence of the tighter interaction of TPR2A with the EEVD
are highly conserved in all TPR domains known to bind motif, the buried surface area is about 100 AÊ 2 larger than
to the C-terminal domains of Hsp70/Hsc70 or Hsp90 the buried surface area calculated for TPR1 in complex
(Figure 3), suggesting that these TPR domains will bind with EEVD only. Met 24 of the Hsp90 peptide engages
to the C-terminal carboxylate of Hsp70 or Hsp90 via a in tight hydrophobic interactions with a cavity mainly
very similar network of electrostatic interactions (see formed by the sidechains of Tyr 236 and Glu 271, and
Figure 4). It is interesting to point out that the TPR2B Val 21 of the EEVD region is binding in a hydrophobic
domain of Hop is predicted to contain all the residues pocket formed by Asn 233, Asn 264 and Ala267.
necessary for binding to EEVD motifs (Figure 3). How- Consistent with the tighter interactions in the Hsp90
ever, attempts to identify a high affinity ligand for TPR2B EEVD region, truncation of MEEVD to EEVD leads to a
have so far been unsuccessful. A search of the nonre- significant but more moderate loss in binding affinity
dundant protein data base revealed seven additional from about 11 to 90 mM, whereas TPR1 binds the EEVD
TPR proteins that may be able to bind a C-terminal peptide only with an affinity of 300 mM (Figures 6A
and 6B).aspartate via a two-carboxylate clamp, including several
Crystal Structures of the TPR Domain±Peptide Complexes
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Figure 6. Thermodynamic Analysis of the Interaction of TPR1 and TPR2A with C-Terminal Sequences of Hsp70 and Hsp90
(A) Binding constants (KD) for the interactions of TPR1 with EEVD peptides were determined by ITC measurements (see Figure 1 and Experimental
Procedures).
(B) Binding of TPR2A to EEVD peptides. GSGSGPTIEEVD are the 12 C-terminal residues of Hsc70. GDDDTSRMEEVD are the 12 C-terminal
residues of Hsp90. Titrations were performed at 258C by injecting peptides dissolved in buffer G at 7.5±15 mM into a solution containing the
TPR1 domain (450±950 mM) in buffer G. Stoichiometry factors (N) typically ranged between 0.9 and 1.1.
(C) Amino acid conservation of cytosolic forms of eukaryotic Hsp70 and Hsc70 proteins (83 sequences analyzed). The conservation of the
most frequent amino acid is indicated in percent. Amino acids of the ordered peptide region are highlighted in bold.
(D) Amino acid conservation of cytosolic forms of eukaryotic Hsp90 proteins (138 sequences analyzed). The last five amino acids predicted
to be important for TPR binding are highlighted in bold.
The regions N-terminal to the EEVD motif differ mark- similar basis for the interaction of Hsp90 proteins with
their respective TPR partners (Figure 6D). Consistentedly between the C termini of Hsp70/Hsc70 and Hsp90
proteins (Figures 6C and 6D), suggesting that these se- with our thermodynamic data, the high level of sequence
conservation predicts that the last five amino acids (con-quences are not only important for binding with high
affinity but also in determining TPR specificity. The eight sensus: MEEVD) are necessary for TPR binding.
The structural alignment of the two complexes (FigureC-terminal amino acids are nearly fully conserved in all
cytosolic forms of eukaryotic Hsp70 and Hsc70 proteins 5) also provides an explanation for how specific binding
of Hsp70 and Hsp90 to the TPR domains of Hop is(consensus: GPTIEEVD), and these are the residues that
are ordered in the crystal structure of the TPR1±peptide achieved. While the last two residues of the Hsp70 and
Hsp90 peptides are bound at equivalent positions in thecomplex. This sequence is probably solvent-exposed
as it is connected to the peptide binding domain of respective TPR domains, the remaining N-terminal parts
of the peptides are binding to very different TPR regions.Hsp70/Hsc70 by a flexible linker region of about nine
amino acids that consists of a series of Ala, Ser, and Whereas the fully conserved VD part of the two peptides
is positioned via electrostatic interactions by the con-Gly residues (Figure 6C). The alignment of the C termini
of the cytosolic forms of eukaryotic Hsp90 suggests a served two-carboxylate clamp within each TPR domain,
Cell
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Figure 7. Superposition of the TPR1±Peptide
Complex with the 14±3±3±Peptide Complex
(A) Overview showing the alignment of the
corresponding a helices and bound peptides.
The TPR1 complex is in magenta, and the
14±3±3 complex structure is in gray. N and C
termini of the domains and the bound pep-
tides are indicated.
(B) Close-up of the TPR1 two-carboxylate
clamp superimposed with equivalent resi-
dues of the 14±3±3 domain.
the divergent N-terminal regions of the peptides are of Hsp90 makes direct contacts with TPR2A, suggesting
that other TPR domains may also interact with the EEVDusing different hydrophobic cavities in the TPR domains
for selective binding. Only weak, nonspecific binding to motif of Hsp70/Hsc70 in this way. For example, a TPR
protein may exclusively contact the EEVD motif and soTPR1 was detected for the C-terminal domain of Hsp90
(C90) and for C90-derived peptides with affinities in the be able to bind to both Hsp70 and Hsp90 with similar
affinities. It also seems possible that the interaction ofsame range measured for the fully conserved EEVD pep-
tide alone (Figure 6A). Similar observations were made the TPR domain with the EEVD peptide may generate a
new interface for the association with an as yet unknownfor the interaction of TPR2A with C70 and C70-derived
peptides (Figure 6B). In this case, short C70 peptides additional factor.
bound to TPR2A with the affinity of the tetrapeptide
EEVD while the C70 domain bound with a significantly A Comparison with Other Peptide Binding Domains
Another class of protein domain that binds to C-terminalreduced affinity (250 mM), suggesting steric incompati-
bility of the C70 domain with TPR2A. sequences of target proteins is the PDZ domain (Doyle
et al., 1996). PDZ domains are structurally related to PTBSurprisingly, neither the structure nor the thermody-
namic data provide an explanation for the high degree (phosphotyrosine binding) and PH (pleckstrin homology)
domains (Harrison, 1996) and share no sequence orof conservation of the two Glu residues in the EEVD
motif of Hsp70. In the TPR1 complex, the sidechains of structural relationship with TPR domains. Instead of
consisting exclusively of a helices, they rather form a/bthese residues are solvent-exposed. It is possible that
tertiary interactions with regions of Hsp70/Hsc70 out- sandwich structures. The PDZ domain recognizes a
C-terminal, four amino acid segment with the consensusside its 25 kDa C-terminal domain may result in in-
creased affinity. In contrast, Glu 23 in the EEVD segment X-Thr/Ser-X-Val-COO2. In the PDZ±peptide complex,
Crystal Structures of the TPR Domain±Peptide Complexes
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Experimental Proceduresthis sequence engages a b sheet of the domain through
antiparallel mainchain interactions (Doyle et al., 1996).
Protein and Peptide PreparationThis mode of binding is completely different from the Codons 1±118 (TPR1) and codons 223±352 (TPR2A) of human Hop
set of interactions described here for the TPR±peptide were cloned in-frame into the EheI site of the plasmid pPROEx HTa
complexes. However, it is interesting to note that in PDZ (Life Sciences) for expression in E. coli BL21 (DE3) cells as fusion
proteins with cleavable, N-terminal hexahistidine tags. The solubledomains, the peptide is also anchored via its C-terminal
proteins were purified by chromatography on Ni-NTA (Qiagen) andcarboxylate and that this anchor seems to be an impor-
Superdex 200 (Pharmacia). His tags were removed using TEV prote-tant feature of the interaction.
ase, leaving an additional glycine residue prior to the N terminus.
Das and coworkers recently noted a distant similarity The proteins were concentrated to 40 mg/ml by ultrafiltration. For
between the respective peptide-free structures of TPR structure determination of TPR2A, a selenomethionine-labeled form
was produced by expression in E.coli strain B834 (DE3) and a sele-domains and 14±3±3 domains (Das et al., 1998). 14±3±3
nomethionine-labeled peptide (C-terminal 5 amino acids of HSP90:domains form homodimers with nine a helices per mono-
MEEVD) was used for cocrystallization. Incorporation of the methio-mer. A comparison of the TPR1±peptide complex with
nines was confirmed by mass spectrometry. The C-terminal frag-
the recently determined structure of a 14±3±3 domain± ment of human Hsp70 (C70, codons 382±641) was cloned, ex-
peptide complex (Yaffe et al., 1997) suggested a differ- pressed, and purified by the same strategy, and the C-terminal
domain of human Hsp90 (C90, codons 625±732) was expressed andent alignment (Figure 7A). Upon fitting the 14±3±3 com-
purified as published (Young et al., 1998).plex onto the TPR1 complex in such a way as to
For the synthesis of Ac-(Se)Met-Glu-Glu-Val-Asp-OH, the L-sele-maximize the fit of the two bound peptides, we noticed
nomethionine was converted into Fmoc-(Se)Met-OH by reaction
a striking superpositioning of functionally important resi- with Fmoc-OSu under standard conditions (crystallization from
dues of the two domains. Five of the TPR1 helices align ethyl acetate/hexane). The tetrapeptide H-Glu(OtBu)-Glu(OtBu)-Val-
well with helices in the 14±3±3 domain (rmsd of 2.5 AÊ ), Asp(OtBu)-resin was synthesized using standard Fmoc/HBTU/HOBt
solid phase protocols on Wang resin (Bachem, Bubendorf). Fmoc-and the five residues of TPR1 that form the two-carbox-
(Se)Met-OH was double-coupled in a 2-fold excess to the peptideylate clamp can be superimposed with residues in 14±
resin with HBTU/HOBt/DIEA (1:1:2). After piperidine-mediated cleav-3±3 that are important for peptide binding (Figure 7B).
age of the Fmoc protection, N-terminal acetylation was performed
Four of these five residues in the 14±3±3 domain are with an 8-fold excess of Ac2O in the presence of DIEA. The resin
responsible for all the electrostatic interactions with the cleavage and deprotection step was performed with argon-satu-
rated TFA/TIS/H2O (93.5:5:1.5) at room temperature for 90 min underbound peptide. It is apparent that large parts of the
argon atmosphere. The resin was filtered off and the product was14±3±3 domain do not have a structural equivalent in
precipitated with methyl tert-butyl ether/hexane. The crude peptideTPR domains. Interestingly, however, the portion of the
was purified by preparative RP-HPLC (elution: linear gradient of
14±3±3 domain that cannot be aligned exclusively medi- 0.1% aqueous TFA and 0.08% TFA in CH3CN). The product was
ates contacts with the phosphate moiety but not with obtained upon lyophilization. All other peptides were synthesized
with acetylated N termini using solid phase FMOC chemistry.other regions of the bound peptide (Figure 7A and Yaffe
et al., 1997). This suggests that TPR domains and 14±3±3
Crystallization and Data Collectiondomains are using the same architectural principles for
Crystals of TPR1 in complex with peptide (GASSGPTIEEVD) were
peptide binding and that the functionality of 14±3±3 do- grown at 208C in hanging drops by vapor diffusion. Equal volumes
mains, i.e., the recognition of phosphorylated serine and (1.5 ml) of protein±peptide complex (protein:peptide 5 1:1.3) at 20
threonine residues, is an additional feature that resides mg/ml in 15 mM HEPES (pH 7.5) were mixed with reservoir solution
containing 100 mM TRIS (pH 8.5), 24% (w/v) PEG MME 2000, 10in a unique structural element outside the core common
mM NiCl2, and 15% (w/v) xylitol. Crystallization was improved byto both domain architectures that is used for sequence-
micro seeding and crystals reached their full size (typically 150 3
specific peptide binding. 150 3 70 mm3) within two weeks. Crystals were flash-cooled in liquid
nitrogen and kept at 100 K during data collection using an Oxford
Cryostream device. Crystals belonged to space group P41 (a 5
75.47 AÊ , c 5 42.89 AÊ ) with 2 molecules per asymmetric unit and aTPR±Hsp Complexes as Potential Drug Targets
solvent content of 45%. Four nickel atoms and four TRIS moleculesThe TPR domains of Hop coordinate the functional co-
are found in the structure. High resolution datasets were collectedoperation of Hsp70/Hsc70 and Hsp90 in the folding of at beamline X12B at the National Synchrotron Light Source in Brook-
a number of proteins that feature prominently in cancer, haven using an ADSC Quantum-4 CCD detector.
including the androgen and estrogen receptors, and Crystals of TPR2A in complex with peptide (MEEVD) were grown
as described above by mixing equal amounts (1.8 ml) of protein±several proto-oncogenic protein kinases. Our results ex-
peptide complex (protein:peptide 5 1:1.3) at 15 mg/ml in 50 mMplain, at a structural level, how specific binding of Hop
TRIS (pH 7.5), 2 mM DDT with reservoir solution containing 100 mMto Hsp70 and Hsp90 is achieved, suggesting TPR-Hsp TRIS (pH 8.5), 20% (w/v) PEG MME 2000, 5 mM NiCl2, and 10% (w/v)
complexes as potential drug targets. Considering the xylitol. Crystals were detectable after 1 week and reached full size
critical role of the EEVD motif in the interaction, it may (typically 100 3 50 3 50 mm3) within 3 weeks. Nickel and the peptide
were found to be essential for crystallization. One highly orderedbe possible to interfere with the binding of Hsp70 or
nickel ion was found in the structure mediating a crystal contactHsp90 to Hop, thereby inhibiting the passage of client
and used for phasing. Crystals belonged to space group C2 with
molecules to Hsp90. Similarly, blocking the binding of one molecule per asymmetric unit and a solvent content of 40%. A
Hsp90 to other TPR partner proteins, such as certain native dataset to 1.9 AÊ resolution was collected on beamline ID14-3
immunophilins, might also reduce the functional levels at ESRF using a MarCCD detector. MAD diffraction data of the
labeled TPR2A±peptide complex were measured on the MPG/GBFof Hsp90 substrates. It is encouraging in this regard that
wiggler beamline BW6/DORIS at DESY using a MarCCD detector.the partial inhibition of Hsp90 function by the ansamycin
Datasets were collected around the absorption edges of Ni (Ni1:
antibiotic geldanamycin can cause the reversion of cer- peak, Ni2: inflection) and Se (Se1: peak, Se2: inflection) from a single
tain tumor growth phenotypes of cells in culture (re- protein crystal. All datasets were processed using the HKL software
package (Otwinowski and Minor, 1997).viewed in Smith et al., 1998).
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Table 1. Data Collection, Phasing, and Refinement Statistics
Data Collection
TPR1 complex TPR2A complex
Space Group P41 C2
Unit Cell a 5 75.47 AÊ a 5 73.28 AÊ , b 5 48.27 AÊ , c 5 38.06 AÊ
c 5 42.89 AÊ b 5 91.308
Number of Molecules/asym. unit 2 1
Nativea Nativeb Ni1a,g Ni2a,g Se1a,g Se2a,g
X-ray source NSLS, X12Bc ESRF, ID14-3d DESY, BW6e
Wavelength (AÊ ) l 5 0.9490 l 5 0.9402 l 5 1.4828 l 5 1.4840 l 5 0.9793 l 5 0.9798
Resolution (AÊ ) 20.0±1.6 15.0±1.9 17.0±2.1
(1.66±1.60) (1.95±1.90) (2.14±2.10)
I/sI 32.5 (3.3) 22.8 (9.0) 22.3 (10.2) 22.8 (10.1) 23.8 (11.1) 25.6 (10.6)
Completeness (%) 95.8 (75.2)f 97.1 (91.7) 93.0 (94.9) 98.8 (98.6) 96.8 (96.8) 88.0 (90.1)
Rsym (%) 4.1 (30.5) 3.8 (6.8) 2.8 (8.3) 3.3 (10.5) 3.3 (8.8) 3.1 (9.0)
MAD Phasingh
Anomalous scatterer 1 Ni, 2 Se
Resolution (AÊ ) 17.0±2.1
Figure of merit 0.74
Rcullis_ano 0.64 0.87 0.65 0.85
Phasing power centric 0.48 Ð 1.51 1.30
Phasing power acentric 0.65 Ð 2.46 2.27
Model Refinementi
Resolution (AÊ ) 20.0±1.6 10.0±1.9
Number of reflections Rwork/Rfree 27704/3100 9217/1003
Rwork/Rfree (%)j 18.0/21.4 18.1/21.9
Number of protein/ligand atoms 1840/120 1042/44
Number of hetero atoms 36 1
Number of solvent molecules 245 152
Rmsd bond length (AÊ ) 0.008 0.008
Rmsd angles (8) 1.3 1.2
a Values as defined in SCALEPACK (Otwinowski and Minor, 1997). b Values as defined in XDS (Kabsch, 1993). c National Synchrotron Light
Source in Brookhaven, beamline X12B. d European Synchrotron Radiation Facility in Grenoble, beamline ID14-3. e Deutsches Elektronen
Synchrotron in Hamburg, beamline BW6. f Drop in higher shell due to rectangular detector shape. g Bijvoet pairs separated. h Unweighted
values as defined in MLPHARE (CCP4, 1994). i Values as defined in CNS (Bruenger et al., 1998). j No sigma cutoffs.
Structure Determination and Refinement difference Patterson map from data at the wavelength of maximal
fNi99 (Ni1). The single nickel site was then used to calculate MADThe structure of the TPR1 complex was solved by molecular replace-
phases with MLPHARE (CCP4, 1994). These phases were used toment using the program Amore as implemented in CCP4 (Bailey,
identify the two selenium sites from an anomalous difference Fourier1994). Parts of a previously determined crystal structure of TPR1L
map calculated with data at maximal fSe99 (Se1). For the final phasing(amino acids 1±140 of Hop) (C. S. and I. M., unpublished data) served
run, the inflection point wavelength of nickel (Ni2) was used as theas a search model. The TPR1±peptide complex was refined with
native data set and the three other wavelengths (Ni1, Se1, Se2) werethe program CNS (Brunger et al., 1998) using all diffraction data
treated as separate derivatives. Phases were calculated betweenbetween 20 and 1.6 AÊ resolution, excluding 10% of the data for
17.0 AÊ and 2.1 AÊ resolution and their initial mean figure of meritcross-validation (Table 1). All refinement steps were performed with-
of 0.74 was improved to 0.88 by solvent flattening and histogramout making use of the noncrystallographic symmetry. The two crys-
matching using the program DM (CCP4, 1994). The resulting electrontallographically independent TPR1 domains (chain A and chain B)
density map was of high quality and allowed wARP (Perrakis et al.,could be traced from residues A2 to A118 and B1 to B115. Owing
1997) to trace roughly 90% of the final structure. The atomic modelsto disorder, residues A2, B1, B2, and B110 were modeled as ala-
were checked and rebuilt using the program O (Jones et al., 1991).nines. The locations of the two peptides were determined from a
Refinements were carried out with the program CNS (BruÈ nger et al.,difference electron density map. In both cases, only the last eight
1998) against the native data set using all diffraction data between
amino acids GPTIEEVD of the peptide could be traced. The differ-
10 and 1.9 AÊ resolution, excluding 10% of the data for cross-valida-
ence electron density map also allowed the identification of four
tion. The chains were traced from Lys223 to Gln349 for the TPR2A
nickel atoms (two per monomer) and four TRIS molecules (two per domain and from Met 24 to Asp 0 for the peptide. Due to disorder,
monomer). Two weak nickel sites were located at His A/B36. The residues A291 to A294 and A348 were modeled as alanines. The
occupancy was manually set to 0.5 to adjust the temperature factors single nickel site used during phasing was found to mediate a crystal
to those of the bound histidines. Two fully occupied sites were contact from His247 to His321 and Lys325 from a symmetry-related
located at His A/B101. Each nickel atom bound to the histidine molecule. The final model, containing 1086 protein atoms (44 for
coordinates additionally two TRIS molecules. The final model, con- the peptide), 1 hetero atom, and 152 solvent molecules converged
taining 1960 protein atoms, 36 hetero atoms, and 245 solvent mole- at Rwork 5 18.1% (Rfree 5 21.9%) for all data without any s cutoff.
cules converged at Rwork 5 18.0% (Rfree 5 21.4%). The root-mean- The root-mean-squared deviation in bond length is 0.008 AÊ and in
square deviation in bond lengths is 0.008 AÊ and in bond angles 1.38. bond angles 1.28. All residues fall in the favored or generously al-
In the description of the structure, we concentrate on one molecule lowed regions of a Ramachandran plot as calculated with the pro-
in complex with its target peptide (chains A and C, respectively). gram PROCHECK (Laskowski et al., 1993).
For TPR2A (Table 1), MAD data sets were put on an approximately
absolute scale and treated as a special case of MIR data using Isothermal Titration Calorimetry
various programs of the CCP4 suite (CCP4, 1994). The position Binding of protein fragments and peptides to the TPR domains was
measured by isothermal titration calorimetry (Wiseman et al., 1989)of one nickel atom was determined by analysis of an anomalous
Crystal Structures of the TPR Domain±Peptide Complexes
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using a MicroCal MCS titration calorimeter (MicroCal Inc., North- domain of Hsc70 provides binding sites for a distinct set of chaper-
one cofactors. Mol. Cell. Biol. 18, 2023±2028.hampton, USA). Forty to fifty aliquots of 5 ml peptide solution (7.5±15
mM) were titrated at 258C by injection into 1.36 ml TPR1 (TPR2A) Dolinski, K.J., Cardenas, M.E., and Heitman, J. (1998). CNS1 en-
solution (450±950 mM) in the chamber. Alternatively, a solution of 3 codes an essential p60/Sti1 homolog in Saccharomyces cerevisiae
mM TPR1 (TPR2A) was titrated into 180 mM C70 (C90) solution that suppresses cyclophilin 40 mutations and interacts with Hsp90.
in the chamber. Peptides were dissolved in and proteins dialyzed Mol. Cell. Biol. 18, 7344±7352.
against buffer G (25 mM HEPES [pH 7.5], 100 mM KAc, and 5 mM Doyle, D.A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon,
MgAc2). Injections were typically continued beyond saturation levels R. (1996). Crystal structures of a complexed and peptide-free mem-
to allow for determination of heats of ligand dilution. After subtrac- brane protein-binding domain: molecular basis of peptide recogni-
tion of dilution heats, calorimetric data were analyzed using the tion by PDZ. Cell 85, 1067±1076.
evaluation software provided by the manufacturer (version 2.9; Mi-
Esnouf, R.M. (1999). Further additions to MolScript version 1.4, in-croCal Software, Inc.).
cluding reading and contouring of electron-density maps. Acta Crys-
tallogr. 55, 938±940.Sequence Searches
Freeman, B.C., Toft, D.O., and Morimoto, R.I. (1996). MolecularThe program PatternFind (http://www.ch.embnet.org/software/
chaperone machines: chaperone activities of the cyclophilin Cyp-PATFND_form.html) was used to search the nonredundant database
40 and the steroid aporeceptor-associated protein p23. Scienceof protein sequences for sequence patterns.
274, 1718±1720.
Acknowledgments Frydman, J., and HoÈ hfeld, J. (1997). Chaperones get in touch: the
Hip-Hop connection. Trends Biochem. Sci. 22, 87±92.
We thank Fred Wittinghofer and Christian Herrmann for help with Harrison, S.C. (1996). Peptide-surface association: the case of PDZ
the microcalorimetry measurements, Lars-Oliver Essen for advice and PTB domains. Cell 86, 341±343.
on the use of programs, the staff of the European Molecular Biology
Hartl, F.U. (1996). Molecular chaperones in cellular protein folding.
Laboratory outstation in Grenoble for access and support at EMBL
Nature 381, 571±579.
beamlines, and Malcolm Capel and John Flanagan for help with
Honore, B., Leffers, H., Madsen, P., Rasmussen, H.H., Vandekerck-data collection at National Synchrotron Light Source beam line
hove, J., and Celis, J.E. (1992). Molecular cloning and expressionX12B. A. B. was supported by a fellowship from the Boehringer
of a transformation-sensitive human protein containing the TPR mo-Ingelheim Foundation.
tif and sharing identity to the stress-inducible yeast protein STI1. J.
Biol. Chem. 267, 8485±8491.Received October 8, 1999; revised March 15, 2000.
Johnson, J.L., and Craig, E.A. (1997). Protein folding in vivo: unravel-
ing complex pathways. Cell 90, 201±204.References
Johnson, B.D., Schumacher, R.J., Ross, E.D., and Toft, D.O. (1998).
Bailey, S. (1994). The Ccp4 SuiteÐprograms for protein crystallogra- Hop modulates Hsp70/Hsp90 interactions in protein folding. J. Biol.
phy. Acta Crystallogr. 50, 760±763. Chem. 273, 3679±3686.
Ballinger, C.A., Connell, P., Wu, Y., Hu, Z., Thompson, L.J., Yin, L.Y., Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991).
and Patterson, C. (1999). Identification of CHIP, a novel tetratrico- Improved methods for building protein models in electron-density
peptide repeat-containing protein that interacts with heat shock maps and the location of errors in these models. Acta Crystallogr.
proteins and negatively regulates chaperone functions. Mol. Cell. 47, 110±119.
Biol. 19, 4535±4545. Kordes, E., Savelyeva, L., Schwab, M., Rommelaere, J., Jauniaux,
Bose, S., Weikl, T., Bugl, H., and Buchner, J. (1996). Chaperone J.C., and Cziepluch, C. (1998). Isolation and characterization of hu-
function of Hsp90-associated proteins. Science 274, 1715±1717. man SGT and identification of homologues in Saccharomyces cere-
visiae and Caenorhabditis elegans. Genomics 52, 90±94.BruÈ nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Kuriyan, J., and Cowburn, D. (1997). Modular peptide recognition
Pannu, N.S., et al. (1998). Crystallography and NMR system: a new domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct.
software suite for macromolecular structure determination. Acta 26, 259±288.
Crystallogr. 54, 905±921. Lamb, J.R., Tugendreich, S., and Hieter, P. (1995). Tetratrico peptide
Buchner, J. (1999). Hsp90 and Co.Ða holding for folding. Trends repeat interactions: to TPR or not to TPR? Trends Biochem. Sci.
Biochem. Sci. 24, 136±141. 20, 257±259.
Caplan, A.J. (1999). Hsp90's secrets unfold: new insights from struc- Lassle, M., Blatch, G.L., Kundra, V., Takatori, T., and Zetter, B.R.
tural and functional studies. Trends Cell Biol. 9, 262±268. (1997). Stress-inducible, murine protein mSTI1. Characterization of
binding domains for heat shock proteins and in vitro phosphorylationCarrello, A., Ingley, E., Minchin, R.F., Tsai, S., and Ratajczak, T.
by different kinases. J. Biol. Chem. 272, 1876±1884.(1999). The common tetratricopeptide repeat acceptor site for ste-
roid receptor- associated immunophilins and hop is located in the Marsh, J.A., Kalton, H.M., and Gaber, R.F. (1998). Cns1 is an essen-
dimerization domain of Hsp90. J. Biol. Chem. 274, 2682±2689. tial protein associated with the hsp90 chaperone complex in Sac-
charomyces cerevisiae that can restore cyclophilin 40±dependentChang, H.C., Nathan, D.F., and Lindquist, S. (1997). In vivo analysis
functions in cpr7Delta cells. Mol. Cell. Biol. 18, 7353±7359.of the Hsp90 cochaperone Sti1 (p60). Mol. Cell. Biol. 17, 318±325.
Merritt, E.A., and Bacon, D.J. (1997). Raster3D: photorealistic molec-Chen, S., and Smith, D.F. (1998). Hop as an adaptor in the heat
ular graphics. Methods Enzymol. 277, 505±524.shock protein 70 (Hsp70) and hsp90 chaperone machinery. J. Biol.
Chem. 273, 35194±35200. Murthy, A.E., Bernards, A., Church, D., Wasmuth, J., and Gusella,
J.F. (1996). Identification and characterization of two novel tetratri-Chen, S., Prapapanich, V., Rimerman, R.A., Honore, B., and Smith,
copeptide repeat-containing genes. DNA Cell Biol. 15, 727±775.D.F. (1996). Interactions of p60, a mediator of progesterone receptor
assembly, with heat shock proteins hsp90 and hsp70. Mol. Endocri- Nagase, T., Ishikawa, K., Suyama, M., Kikuno, R., Miyajima, N., Ta-
nol. 10, 682±693. naka, A., Kotani, H., Nomura, N., and Ohara, O. (1998). Prediction
of the coding sequences of unidentified human genes. XI. The com-Chen, S., Sullivan, W.P., Toft, D.O., and Smith, D.F. (1998). Differen-
plete sequences of 100 new cDNA clones from brain which codetial interactions of p23 and the TPR-containing proteins Hop, Cyp40,
for large proteins in vitro. DNA Res. 5, 277±286.FKBP52 and FKBP51 with Hsp90 mutants. Cell Stress Chaperones
3, 118±129. Nicholls, A., Bharadwaj, R., and Honig, B. (1993). Grasp - graphical
representation and analysis of surface properties. Biophys. J. 64,Das, A.K., Cohen, P.W., and Barford, D. (1998). The structure of the
A166±A166.tetratricopeptide repeats of protein phosphatase 5: implications for
TPR-mediated protein±protein interactions. EMBO J. 17, 1192±1199. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction
data collected in oscillation mode. Methods Enzymol. 276, 307±326.Demand, J., Luders, J., and Hohfeld, J. (1998). The carboxy-terminal
Cell
210
Owens-Grillo, J.K., Czar, M.J., Hutchison, K.A., Hoffmann, K., Per-
dew, G.H., and Pratt, W.B. (1996). A model of protein targeting
mediated by immunophilins and other proteins that bind to hsp90 via
tetratricopeptide repeat domains. J. Biol. Chem. 271, 13468±13475.
Perrakis, A., Morris, R., and Lamzin, V.S.(1999). Automated protein
model building combined with iterative structure refinement. Nat.
Struct. Biol. 5, 458±463.
Pratt, W.B. (1997). The role of the hsp90-based chaperone system
in signal transduction by nuclear receptors and receptors signaling
via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37, 297±326.
Pratt, W.B., and Toft, D.O. (1997). Steroid receptor interactions with
heat shock protein and immunophilin chaperones. Endocr. Rev. 18,
306±360.
Prodromou, C., Roe, S.M., Obrien, R., Ladbury, J.E., Piper, P.W.,
and Pearl, L.H. (1997). Identification and structural characterization
of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell
90, 65±75.
Prodromou, C., Siligardi, G., O'Brien, R., Woolfson, D.N., Regan, L.,
Panaretou, B., Ladbury, J.E., Piper, P.W., and Pearl, L.H. (1999).
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat
(TPR)-domain co-chaperones. EMBO J. 18, 754±762.
Smith, D.F., Sullivan, W.P., Marion, T.N., Zaitsu, K., Madden, B.,
McCormick, D.J., and Toft, D.O. (1993). Identification of a 60-kilodal-
ton stress-related protein, p60, which interacts with hsp90 and
hsp70. Mol. Cell. Biol. 13, 869±876.
Smith, D.F., Whitesell, L., and Katsanis, E. (1998). Molecular chaper-
ones: biology and prospects for pharmacological intervention. Phar-
macol. Rev. 50, 493±513.
Stebbins, C.E., Russo, A.A., Schneider, C., Rosen, N., Hartl, F.U., and
Pavletich, N.P. (1997). Crystal structure of an Hsp90-geldanamycin
complex: targeting of a protein chaperone by an antitumor agent.
Cell 89, 239±250.
Su, G., Roberts, T., and Cowell, J.K. (1999). TTC4, a novel human
gene containing the tetratricopeptide repeat and mapping to the
region of chromosome 1p31 that is frequently deleted in sporadic
breast cancer. Genomics 55, 157±163.
Tsukahara, F., Hattori, M., Muraki, T., and Sakaki, Y. (1996). Identifi-
cation and cloning of a novel cDNA belonging to tetratricopeptide
repeat gene family from Down syndrome-critical region 21q22.2. J.
Biochem. (Tokyo) 120, 820±827.
Wallace, A.C., Laskowski, R.A., and Thornton, J.M. (1995). LigplotÐ
a program to generate schematic diagrams of protein ligand interac-
tions. Protein Eng. 8, 127±134.
Wiseman, T., Williston, S., Brandts, J.F., and Lin, L.N. (1989). Rapid
measurement of binding constants and heats of binding using a
new titration calorimeter. Anal. Biochem. 179, 131±137.
Yaffe, M.B., Rittinger, K., Volinia, S., Caron, P.R., Aitken, A., Leffers,
H., Gamblin, S.J., Smerdon, S.J., and Cantley, L.C. (1997). The struc-
tural basis for 14±3±3:phosphopeptide binding specificity. Cell 91,
961±971.
Young, J.C., Obermann, W.M. J., and Hartl, F.U. (1998). Specific
binding of tetratricopeptide repeat proteins to the C-terminal 12-
kDa domain of hsp90. J. Biol. Chem. 273, 18007±18010.
Zhang, M.L., Wang, L.F., Miao, S.Y., and Koide, S.S. (1992). Isolation
and sequencing of the cDNA encoding the 75-kD human sperm
protein related to infertility. Chin. Med. J. (Engl) 105, 998±1003.
Protein Data Bank Accession Codes
The TPR1 and TPR2A complexes have been deposited in the Protein
Data Bank with accession codes 1ELW and 1ELR, respectively.
